MC
ABMD

Menta Capital’s Abiomed Inc ABMD Stock Holding History

Menta Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,306
Closed -$1.49M – 714
2018
Q3 		$1.49M Buy
3,306
+86
+3% +$33.9K 0.52% 23
2018
Q2 		$1.32M Buy
3,220
+1,880
+140% +$681K 0.31% 67
2018
Q1 		$390K Buy
+1,340
New +$340K 0.08% 402
2017
Q3 		– Sell
-3,580
Closed -$513K – 895
2017
Q2 		$513K Buy
+3,580
New +$481K 0.06% 526
2016
Q2 		– Sell
-13,223
Closed -$1.25M – 1016
2016
Q1 		$1.25M Buy
13,223
+1,200
+10% +$101K 0.17% 139
2015
Q4 		$1.08M Buy
12,023
+6,700
+126% +$569K 0.14% 234
2015
Q3 		$494K Buy
5,323
+1,133
+27% +$99.8K 0.08% 444
2015
Q2 		$275K Sell
4,190
-1,710
-29% -$114K 0.04% 541
2015
Q1 		$422K Buy
+5,900
New +$320K 0.05% 490

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Menta Capital's ABMD Position: Q4 2018 in Review

Menta Capital sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 3,306 shares — an estimated $1.49M sold.

Menta Capital first reported a position in ABMD in Q1 2015 and held it in 9 quarters. The position peaked at $1.49M in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Menta Capital reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Menta Capital sold 3,306 Abiomed Inc shares in Q4 2018, an estimated $1.49M.
  • Menta Capital first reported a position in Abiomed Inc in Q1 2015 and held it in 9 quarters.
  • Menta Capital's Abiomed Inc position peaked at $1.49M in Q3 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Menta Capital's 13F filing for Q4 2018, filed 14 Feb 2019.